Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab-Reference-Cited by-同舟云学术

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Published:2024-08 Issue:8 Volume:8 Page:733-743
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Cai Cindy X.,Nishimura Akihiko^ORCID,Bowring Mary G.^ORCID,Westlund Erik^ORCID,Tran Diep^ORCID,Ng Jia H.,Nagy Paul,Cook Michael,McLeggon Jody-Ann^ORCID,DuVall Scott L.^ORCID,Matheny Michael E.^ORCID,Golozar Asieh^ORCID,Ostropolets Anna^ORCID,Minty Evan,Desai Priya,Bu Fan^ORCID,Toy Brian^ORCID,Hribar Michelle^ORCID,Falconer Thomas^ORCID,Zhang Linying,Lawrence-Archer Laurence,Boland Michael V.^ORCID,Goetz Kerry^ORCID,Hall Nathan^ORCID,Shoaibi Azza,Reps Jenna,Sena Anthony G.^ORCID,Blacketer Clair^ORCID,Swerdel Joel^ORCID,Jhaveri Kenar D.^ORCID,Lee Edward,Gilbert Zachary^ORCID,Zeger Scott L.,Crews Deidra C.^ORCID,Suchard Marc A.^ORCID,Hripcsak George^ORCID,Ryan Patrick B.

Funder

NEI

Publisher

Elsevier BV

Reference47 articles.

1. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study;Lancet Glob Health,2021

2. Evolution of intravitreal therapy for retinal diseases-from CMV to CNV: the LXXIV Edward Jackson memorial lecture;Martin;Am J Ophthalmol,2018

3. Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence;Hanna;Kidney Int,2019

4. Renal effects of anti-angiogenesis therapy: update for the internist;Gurevich;Am J Med,2009

5. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center;Izzedine;Medicine,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal Anti-VEGF Pharmacotherapy and Kidney Failure: Protecting Vision with an Eye on Renal Safety;Ophthalmology Retina;2024-08